Search Results - "Douka, Vassiliki"

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece by Gavriilaki, Eleni, Tragiannidis, Athanasios, Papathanasiou, Maria, Besikli, Sotiria, Karvouni, Paraskevi, Douka, Vassiliki, Paphianou, Eleni, Hatzipantelis, Emmanuel, Papaioannou, Giorgos, Athanasiadou, Anastasia, Marvaki, Anastasia, Panteliadou, Alkistis-Kira, Vardi, Anna, Batsis, Ioannis, Syrigou, Antonia, Mallouri, Despina, Lalayanni, Chrysavgi, Sakellari, Ioanna

“…Bone marrow failure (BMF) syndromes are a group of various hematological diseases with cytopenia as a main common characteristic. Given their rarity and…”
Get full text

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival by Katodritou, Eirini, Kyrtsonis, Marie-Christine, Delimpasi, Sosana, Kyriakou, Despoina, Symeonidis, Argiris, Spanoudakis, Emmanouil, Vasilopoulos, Georgios, Anagnostopoulos, Achilles, Kioumi, Anna, Zikos, Panagiotis, Aktypi, Anthi, Briasoulis, Evangelos, Megalakaki, Aikaterini, Repousis, Panayiotis, Adamopoulos, Ioannis, Gogos, Dimitrios, Kotsopoulou, Maria, Pappa, Vassiliki, Papadaki, Eleni, Fotiou, Despoina, Nikolaou, Eftychia, Giannopoulou, Evlambia, Hatzimichael, Eleftheria, Giannakoulas, Nikolaos, Douka, Vassiliki, Kokoviadou, Kyriaki, Timotheatou, Despoina, Terpos, Evangelos

“…We evaluated progression-free survival (PFS) rate of patients treated with lenalidomide/dexamethasone (Len/Dex), the efficacy of the combination, and the…”
Get full text

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change by Gavriilaki, Eleni, Sakellari, Ioanna, Mallouri, Despina, Batsis, Ioannis, Chatziconstantinou, Thomas, Vardi, Anna, Bousiou, Zoi, Masmanidou, Marianna, Douka, Vassiliki, Syrigou, Antonia, Sotiropoulos, Damianos, Constantinou, Varnavas, Anagnostopoulos, Achilles

Get full text

Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia by Smilevska, Tatjana, Stamatopoulos, Kostas, Samara, Maria, Belessi, Chrysoula, Tsompanakou, Aliki, Paterakis, George, Stavroyianni, Niki, Athanasiadou, Ioanna, Chiotoglou, Ioanna, Hadzidimitriou, Anastasia, Athanasiadou, Anastasia, Douka, Vassiliki, Saloum, Riad, Laoutaris, Nikolaos, Anagnostopoulos, Achilles, Fassas, Athanasios, Stathakis, Nikolaos, Kollia, Panagoula

“…Transferrin receptor (TfR)-1 and 2 mRNA and CD71 (TfR1) expression was analyzed in 118 CLL patients. Ninety-five out of 109 analyzed cases expressed CD71,…”
Get full text

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD) by Demosthenous, Christos, Sakellari, Ioanna, Douka, Vassiliki, Papayanni, Penelope Georgia, Anagnostopoulos, Achilles, Gavriilaki, Eleni

“…Background: Myeloid-derived suppressor cells (MDSCs) are implicated in the complex interplay involving graft-versus-leukemia (GVL) effects and…”
Get full text

Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment by Demosthenous, Christos, Lalayanni, Chrysavgi, Iskas, Michalis, Douka, Vassiliki, Pastelli, Nikoleta, Anagnostopoulos, Achilles

“…Blinatumomab, a bispecific T-cell engager antibody construct targeting CD19, has been shown to improve the outcome in patients with relapsed and/or refractory…”
Get full text

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study by Sakellari, Ioanna, Gavriilaki, Eleni, Chatziioannou, Konstantinos, Papathanasiou, Maria, Mallouri, Despina, Batsis, Ioannis, Bousiou, Zoi, Bouziana, Stella, Constantinou, Varnavas, Douka, Vassiliki, Apostolou, Chrysa, Iskas, Michalis, Lalayanni, Chrysavgi, Athanasiadou, Anastasia, Sotiropoulos, Damianos, Yannaki, Evangelia, Gianouzakos, Vasilis, Anagnostopoulos, Achilles

“…The role of total body irradiation (TBI) in allogeneic hematopoietic stem cell transplantation (HCT) for adult acute lymphoblastic leukemia (ALL) remains…”
Get full text

Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study by Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Katodritou, Eirini, Kyrtsonis, Marie-Christine, Douka, Vassiliki, Spanoudakis, Emmanouil, Papatheodorou, Athanasios, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Gavriatopoulou, Maria, Makras, Polyzois, Kastritis, Efstathios, Dimopoulos, Meletios A

“…Carfilzomib with dexamethasone (Kd) is a well-established regimen for the treatment of relapsed/refractory multiple myeloma (RRMM). There is limited…”
Get full text

Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities by Vyrides, Niki, Douka, Vassiliki, Gavriilaki, Eleni, Papaioannou, Georgios, Athanasiadou, Anastasia, Neofytou, Sofia, Vyrides, Yiannis, Lalayanni, Chrysavgi, Anagnostopoulos, Achilles, Kokoris, Styliani I

“…•Our report highlights the importance of PNH testing even in patients with an established MDS diagnosis when hypoplastic bone marrow and/or dysplasia with…”
Get full text

Long-Term Outcomes of Total Body Irradiation Plus Cyclophosphamide Versus Busulfan Plus Cyclophosphamide As Conditioning Regimen for Acute Lymphoblastic Leukemia: A Comparative Study by Sakellari, Ioanna, Gavriilaki, Eleni, Chatziioannou, Konstantinos, Papathanasiou, Maria, Mallouri, Despina, Batsis, Ioannis, Bousiou, Zoi, Bouziana, Stella, Constantinou, Varnavas, Douka, Vassiliki, Apostolou, Chrysa, Marvaki, Anastasia, Kaliou, Maria, Iskas, Michalis, Sotiropoulos, Damianos, Yannaki, Evangelia, Smias, Christos, Gianouzakos, Vasilis, Anagnostopoulos, Achilles

“…Introduction: Total body irradiation-Cyclophosphamide (TBI-Cy) and Busulfan-Cyclophosphamide (Bu-Cy) are the most commonly used conditioning regimens in…”
Get full text

IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications by VARDI, Anna, AGATHANGELIDIS, Andreas, GHIA, Paolo, BELESSI, Chrysoula, STAMATOPOULOS, Kostas, SUTTON, Lesley-Ann, CHATZOULI, Maria, SCARFO, Lydia, MANSOURI, Larry, DOUKA, Vassiliki, ANAGNOSTOPOULOS, Achilles, DARZENTAS, Nikos, ROSENQUIST, Richard

“…Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD…”
Get full text

Revisiting Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Combined Clinicobiological Approach by Baliakas, Panagiotis, Xochelli, Aliki, Minga, Eva, Hadzidimitriou, Anastasia, Douka, Vassiliki, Karavalakis, George, Chouvarda, Ioanna, Maglaveras, Nikolaos, Belessi, Chrysoula, Stamatopoulos, Kostas, Stavroyianni, Niki, Anagnostopoulos, Achilles

“…Chronic lymphocytic leukemia (CLL) is characterized by progressive hypogammaglobulinemia that can affect one or more immunoglobulin subclasses. Although many…”
Get full text

An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit by Ioakimidou, Aliki, Vyzantiadis, Timoleon-Achilleas, Sakellari, Ioanna, Arabatzis, Michael, Smias, Christos, Douka, Vassiliki, Velegraki, Aristea, Anagnostopoulos, Achilleas, Malissiovas, Nikolaos

“…Abstract The genus Acremonium (formerly known as Cephalosporium ) is a large polyphyletic fungal genus that comprises approximately 150 phylogenetically…”
Get full text

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival by Katodritou, Eirini, Kyrtsonis, Marie-Christine, Delimpasi, Sosana, Kyriakou, Despoina, Symeonidis, Argiris, Spanoudakis, Emmanouil, Vasilopoulos, Georgios, Anagnostopoulos, Achilles, Kioumi, Anna, Zikos, Panagiotis, Aktypi, Anthi, Briasoulis, Evangelos, Megalakaki, Aikaterini, Repousis, Panayiotis, Adamopoulos, Ioannis, Gogos, Dimitrios, Kotsopoulou, Maria, Pappa, Vassiliki, Papadaki, Eleni, Fotiou, Despoina, Nikolaou, Eftychia, Giannopoulou, Evlambia, Hatzimichael, Eleftheria, Giannakoulas, Nikolaos, Douka, Vassiliki, Kokoviadou, Kyriaki, Timotheatou, Despoina, Terpos, Evangelos

“…The original version of this article contained a mistake. The name of Eirini Katroditou should have been Eirini Katodritou. The original article has been…”
Get full text

V617F JAK2 Mutation and Bone Marrow Fibrosis Define Subgroups Of Patients With Polycythemia Vera and Essential Thrombocythemia With Shared Clinicobiological Profiles by Baliakas, Panagiotis, Douka, Vassiliki, Iskas, Michalis, Touloumenidou, Tasoula, Paleta, Angeliki, Koravou, Eva, Cheva, Anta, Iordanidis, Fotis, Sakkas, Leonidas, Sotiropoulos, Damianos, Stamatopoulos, Kostas, Anagnostopoulos, Achilles

“…The JAK2 V617F mutation is of high diagnostic value in the evaluation of myeloproliferative neoplasms (MPN) as it helps to document clonality; in addition, it…”
Get full text

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy? by Chatzilari, Elisavet, Baliakas, Panagiotis, Xochelli, Aliki, Maronidis, Anastasios, Vardi, Anna, Mattsson, Mattias, Larsson, Karin, Douka, Vassiliki, Iskas, Michail, Karavalakis, George, Papalexandri, Apostolia, Niemann, Carsten, Montillo, Marco, Anagnostopoulos, Achilles, Oscier, David, Pospisilova, Sarka, Davi, Frederic, Stavroyianni, Niki, Ghia, Paolo, Hadzidimitriou, Anastasia, Rosenquist, Richard, Nikolopoulos, Spiros, Stamatopoulos, Kostas, Kompatsiaris, Yannis

“…The remarkable clinical heterogeneity of CLL has prompted several initiatives towards the development of prognostic models aiming to stratify patients into…”
Get full text

Splenic marginal-zone lymphoma : One or more entities? a histologic, immunohistochemical, and molecular study of 42 cases by PAPADAKI, Theodora, STAMATOPOULOS, Kostas, BELESSI, Chrysoula, POULIOU, Evi, PARASI, Aikaterini, DOUKA, Vassiliki, LAOUTARIS, Nikolaos, FASSAS, Athanasios, ANAGNOSTOPOULOS, Achilles, ANAGNOSTOU, Dimitra

“…We analyzed 42 splenic marginal-zone lymphoma (SMZL) cases diagnosed on splenectomy specimens after established World Health Organization criteria. A…”
Get full text

A matched pair analysis of conditioning BuEM versus BEAM in autologous haematopoietic cell transplantation for lymphomas in terms of toxicity and efficacy by Sakellari, Ioanna, Mallouri, Despina, Batsis, Ioannis, Apostolou, Chryssoula, Konstantinou, Varnavas, Abela, Elma Maria, Douka, Vassiliki, Marvaki, Anastasia, Karypidis, Kyriakos, Michail, Iskas, Baliakas, Panayiotis, Kaloyannidis, Panayiotis, Yannaki, Evangelia, Kouvatseas, George, Smias, Christos, Anagnostopoulos, Achilles

“…Abstract only 8567 Background: In autologous hematopoietic cell transplantation (AHCT) for lymphomas, the optimal conditioning regimen is currently…”
Get full text

Efficacy and Toxicity of Conditioning Regimens BEAM and BEM in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results of a Comparative (Matched Pair) Analysis by Sakellari, Ioanna, Mallouri, Despina, Ioannis, Batsis, Varnavas, Constantinou, Michalis, Iskas, Panayotis, Baliakas, Kyriakos, Karypidis, Elissavet, Georgiadou, Vassiliki, Douka, Elma, Ampela, Marvaki, Anastasia, Chrysoula, Apostolou, Sotiropoulos, Damianos, Yannaki, Evangelia, Kaloyannidis, Panayotis, Anagnostopoulos, Achilles

“…Abstract 4530 Autologous hematopoietic cell transplantation (AHCT) is the standard of care for relapsed or primary refractory Hodgkin’s (HL) and Non Hodgkin’s…”
Get full text

Distinct Profiles of in Vivo Class Switch Recombination in Chronic Lymphocytic Leukemia Subsets with Stereotyped B Cell Receptors, Suggestive of Distinct Modes of Activation by Antigen by Xochelli, Aliki, Stalika, Evangelia, Sutton, Lesley-Ann, Douka, Vassiliki, Karypidou, Maria, Iskas, Michalis, Chatzouli, Maria, Dagklis, Antonis, Anagnostopoulos, Achilles, Ghia, Paolo, Rosenquist, Richard, Darzentas, Nikos, Belessi, Chrysoula, Stamatopoulos, Kostas

“…Abstract 1777 Antigen stimulation through the B cell receptor (BcR) is critical in CLL ontogeny as evidenced by the distinct prognosis of cases with different…”
Get full text